<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200131046322N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-09</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of exercise on rheumatoid arthritis</public_title>
      <acronym></acronym>
      <scientific_title>The effect of 8 weeks of  home exercise training on quality of life and quality of disease in patients with rheumatoid arthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>81</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45522</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Patients who were included in the study were randomly divided into three groups of aerobic exercise and strength exercise and control group. Intervention groups received exercise therapy in addition to drug therapy for 8 weeks but control group only received medication for 8 weeks.At the begining and the end of study assessment tools for three groups were evaluated, Randomization description: Patients will be randomly assigned into three study arms using a closed envelope A for control, B for intervention group (1) and C for intervention group (2), Blinding description: Participants were unaware of the allocation of study groups That is, they did not know that there were two groups of exercise therapists in clinical trials but were aware of their group's exercise therapy.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Rheumatoid arthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Aerobic exercise (walking) and medication .Aerobic exercise training was recommended for 2 weeks, three to five days a week,  30 to 60 minutes daily, with an intensity of 60 to 80 percent of maximum heart rate. Intervention 2: Intervention group: Strength Exercise Therapy (Weight) and medication .Strength training was taught to patients by dumbbells for 8 week, 2 to 3 days a week, 2 to 3 sets with 8 to 12 repetitions with an intensity 60 to 80% of One-repetition maximum. Intervention 3: Control group: Medication.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All patient data will be published as non-identifiable files for one year after the publication of the article for clinical and academic researchers.

When:
Applicants will be able to access the data 6 months after the paper printout for one year.

To whom:
Academic and Clinical Researchers

Conditions:
Use the document only with the permission of the lead researcher and with the condition of participation in the ongoing research work.

Where to obtain:
1-Zahra Madani to Email Adress: z.madani@mazums.ac.ir
2-Afshin Dayer to Email Adress: afshin.dayer@gmail.com

How to obtain:
The request must first be submitted by email.The person must be fully identifiable with the credentials and indicate the exact reason for the request.After the request is confirmed and the applicant have been identified , the data will be made available to the applicant within one week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Madani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 6 , Mostafavian Clinic , 3th Ave , Razi St</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816868890</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>z.madani@mazums.ac.ir</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afshin Dayer</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 6 , Mostafavian Clinic , 3th Ave , Razi St</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816868890</zip>
        <telephone>+98 11 3336 6552</telephone>
        <email>afshin.dayer@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient was diagnosed with rheumatoid arthritis based on the diagnostic criteria and get rheumatologist approval.
Patient age between 30 and 60 years
The duration of illness is less than 10 years from diagnosis.
The patient has no deformity.
Do not be in active phase of inflammation while performing patient plan.
The severity of the disease was less than 3.2 based on criteria DAS28, It means the severity of the disease is mild or in remission.
The patient should take a lower dose of 15 mg corticosteroid.
The patient is not a high risk cardiovascular risk factor.(Severe diabetes, severe hypertension, severe cardiovascular disease)
Do not experience trauma or fracture or soft tissue damage during design.
Do not suffer from problems such as psychosis or severe depression for psychological issues.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The patient is not satisfied with the plan or has no reason to continue cooperating while performing the plan.
Unable to cooperate in field exercise test (6 minutes walk) and One-repetition maximum test.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M05.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Rheumatoid arthritis with rheumatoid factor, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Aerobic exercise (walking) and medication .Aerobic exercise training was recommended for 2 weeks, three to five days a week,  30 to 60 minutes daily, with an intensity of 60 to 80 percent of maximum heart rate.</i_keyword>
      <i_keyword>Intervention group: Strength Exercise Therapy (Weight) and medication .Strength training was taught to patients by dumbbells for 8 week, 2 to 3 days a week, 2 to 3 sets with 8 to 12 repetitions with an intensity 60 to 80% of One-repetition maximum.</i_keyword>
      <i_keyword>Control group: Medication</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity score of rheumatoid arthritis using Disease Activity Score (DAS)28 questionnaire. Timepoint: Before and after intervention. Method of measurement: Disease Activity Score (DAS)28 questionnaire.</prim_outcome>
      <prim_outcome>Determining the quality of life of patients using WHOQOL-BREF short questionnaire. Timepoint: Before and after intervention. Method of measurement: WHOQOL-BREF short questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Chest press One-repetition maximum test. Timepoint: Before and after the intervention of strength exercise. Method of measurement: Machine chest press.</sec_outcome>
      <sec_outcome>Leg press one-repetition maximum test. Timepoint: Before and after the intervention of strength exercise. Method of measurement: Machine leg press.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-01-26</approval_date>
        <contact_name>Organizational Ethics Committee of Imam Hospital of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Amir Mazandarani Ave, Imam Khomeini Hospital Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
